Toxicology of Selected Nitric Oxide-Donating Xenobiotics, with Particular Reference to Azide
Authors:
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Critical Reviews in Toxicology
- Vol. 24 (4) , 355-377
Abstract
Nitric oxide (NO) has been discovered recently to be a ubiquitous, endogenous mediator, which is responsible for a variety of normal physiological functions. However, NO also has been implicated in several pathophysiological processes. For example, the pulmonary toxicity of various nitrogen oxides, including NO, found in photochemical smog has been studied for decades; endogenous NO also is associated with bleomycin-induced lung damage, as well as other adverse effects. Recently, a variety of xenobiotics have been shown to owe their biological activityin vivo to their biotransformation to NO. Thus, the therapeutic vasodilatation produced by drugs such as nitroglycerin and sodium nitroprusside is now believed to result from their release of NO, which then mimics the effects of endogenously synthesized NO. The toxic effects of NO prodrugs are, therefore, a matter of concern, especially the extent to which, if any, NO contributes to their toxicity. As reviewed here, NO does not appear to contribute importantly to the toxicity of the NO donors nitrite, hydroxylamine, or nitroprusside. However, it is by no means clear whether or not the NO generatedin vivo from sodium azide contributes in a major way to its toxicity. Azide is almost as acutely toxic as cyanide, with which it shares a number of biological effects; yet, azide also has certain cardiovascular actions in common with nitrite. Unlike either cyanide or nitrite, some evidence suggests a tendency for azide to produce low-grade cumulative toxicity. In laboratory animals, azide frequently produces nonasphyxial convulsions, whereas most human deaths appear to be the result of cardiovascular collapse. Neither of these azide-induced syndromes appears to be due to the inhibition of cytochromec oxidase. Azide is widely used as a preservative in aqueous laboratory reagents and as the propellant in automobile air bags and aircraft escape chutes. Both of these inflatable systems are generally safe, and will prevent untold numbers of injuries and deaths. However, to protect workers who handle these devices and others who may come into contact with the sodium azide propellant in these systems, our rudimentary knowledge of azide toxicity needs to be expanded.Keywords
This publication has 98 references indexed in Scilit:
- Nitric oxide generation from nitroprusside by vascular tissueBiochemical Pharmacology, 1991
- Acute neurotoxicity of sodium azide and nitric oxide*1Fundamental and Applied Toxicology, 1991
- Quantitation of nitric oxide formation from nitrovasodilator drugs by chemiluminescence analysis of headspace gasJournal of Pharmacological Methods, 1991
- Signal transduction mechanisms involving nitric oxideBiochemical Pharmacology, 1991
- Generation of valency hybrids and nitrosylated species of hemoglobin in mice by nitric oxide vasodilatorsToxicology and Applied Pharmacology, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Red blood cells generate nitric oxide from directly acting, nitrogenous vasodilatorsToxicology and Applied Pharmacology, 1987
- Hypotensive effects of hydroxylamine in intact anesthetized dogs and catsArchives of Toxicology, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980
- Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparationsProceedings of the National Academy of Sciences, 1977